Oesophageal and Gastric Cancer

Oesophageal and gastric cancer account for around 6% of all cancers in men and 3% of all cancers in women. These cancers typically affect people aged between 60 and 80 years, with the most important risk factors being severe, longstanding gastro-oesophageal reflux disease (GORD), smoking and heavy alcohol consumption. There were 34,534 new cases of oesophageal cancer recorded in the EU in 2012, with an incidence rate of 6.9 per 100,000 population. 

View further information and gain expert opinion on oesophageal and gastric cancer below. All information is taken from the UEG Survey of Digestive Health Across Europe, unless otherwise stated. 

Oesophageal and Gastric Cancer
  • There were more than 80,000 new cases of gastric cancer reported in the EU in 2012
  • The incidence rate for gastric cancer is 16 per 100,000 of the population
  • This was almost twice as high among men (20.6 per 100,000) than among women (11.7 per 100,000)
  • Reported one and five-year survival following diagnosis with gastric cancer was 46% and 21% across Europe from 2000 to 2012
  • Surgical resection for cure is achieved in about 40% of cases and five-year survival after surgical resection is closely related to the spread of the tumour, varying from 95% for early cancers to only 20% for extensive lesions
  • Persistent indigestion
  • Heartburn
  • Pain in stomach or breastbone
  • Trapped wind and frequent burning
  • Main risk factor is longstanding infection with h.pylori which is the causal agent in approximately 75% of cases
  • Genetic susceptibility and family history
  • Poor hygiene
  • Heavy alcohol consumption
  • There were 34,534 new cases of oesophageal cancer recorded in the EU in 2012
  • The incidence rate of oesophageal cancer is 6.9 per 100,000 of the population
  • Oesophageal cancer is most commonly diagnosed in people aged between 60 and 80 years
  • Incidence was more than three times higher in men (10.2 per 100,000) then women 
  • WHO figures for 2012 show that the highest incidence of oesophageal occurs in North Western European nations, particularly the UK, the Netherlands, and Ireland
  • Reported survival for oesophageal cancer in Europe overall from 2000 to 2012 was 39% at one year and 12% at five years
  • The poor prognosis is largely due to the spread of malignancies before diagnosis
  • Difficulty swallowing
  • Weight loss
  • Persistent indigestion
  • Severe longstanding Gastro-oesophageal reflux disease (GORD) OR Barrett's oesophagus
  • Smoking
  • High alcohol consumption
  • Obesity
  • Diets low in fibre
  • Frequent consumption of very hot drinks

Speak to one of our experts to learn more about oesophageal and gastric cancer. Please email media@ueg.eu for further information (full contact details can be found at the bottom of the page).


UEG PR & Media Relations

Luke Paskins

UK Office
The Hay Loft
Balcombe Place Stables
Balcombe / West Sussex
RH17 6QJ

T +44 (0) 1444 811099